Leah Jackson in Ontario, Oregon

Home Oregon Ontario

Leah Jackson has Nurse Practitioner as her primary medical specialty. Their primary office is: 351 Sw 9th St in Ontario, Oregon.

They're a part of the: Apogee Medical Group Pc medical group which has around 19 members. You can call their office at 541-881-7423 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2014 (around 10 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Leah Jackson Office Phone and Directions

Leah Jackson
Apogee Medical Group Pc
351 Sw 9th St
Ontario, Oregon 97914
541-881-7423

Patient Ratings
Please rate your experience with Leah Jackson below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 541-881-7423

Enter a starting address:

Healthcare Info for Leah Jackson

Medical School: Sorry, her university is not listed
Graduation Year: 2014
The Primary Medical Specialty for Leah Jackson is listed as: Nurse Practitioner
Approximate Years of Experience: 10
PAC (PECOS ID)#: 9032540141
NPI #: 1730692989
NPI Created On: 11/09/2017
NPI Last Updated Listed as: 10/13/2023
Primary Taxonomy Code: 163W00000X
License Number:
RN00155803
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Initial hospital inpatient care, typically 70 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788624721

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30